Genetic aspects of vasovagal syncope: A systematic review of current evidence

Europace

Volumn 11, Issue 4, 2009, Pages 414-420

  Olde Nordkamp, Louise R A ^a   Wieling, Wouter ^a   Zwinderman, Aeilko H ^a   Wilde, Arthur A M ^a   Van Dijk, Nynke ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Family history; Genetics; Syncope; Twins; Vasovagal syncope

Indexed keywords

DISEASE ASSOCIATION; FAMILY HISTORY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INCIDENCE; PRESSORECEPTOR; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SYNCOPE; SYSTEMATIC REVIEW; TWINS; VAGUS NERVE;

ALLELES; CLUSTER ANALYSIS; HUMANS; LINKAGE (GENETICS); POLYMORPHISM, GENETIC; SYNCOPE, VASOVAGAL;

EID: 65249149018     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun387     Document Type: Review

References (60)

1. Brignole M, Alboni P, Benditt DG, Bergfeldt L, Blanc JJ, Bloch Thomson PE et al. Guidelines on management (diagnosis and treatment) of syncope - update 2004. Europace 2004;6:467-537.
2. Ganzeboom KS, Mairuhu G, Reitsma JB, Linzer M, Wieling W, van Dijk N. Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35-60 years. J Cardiovasc Electrophysiol 2006;17:1172-6.
3. Sheldon RS, Sheldon AG, Connolly SJ, Morillo CA, Klingenheben T, Krahn AD et al. Age of first faint in patients with vasovagal syncope. J Cardiovasc Electrophysiol 2006;17:49-54.
4. van Dijk N, Sprangers MA, Boer KR, Colman N, Wieling W, Linzer M. Quality of life within one year following presentation after transient loss of consciousness. Am J Cardiol 2007;100:672-6.
5. Rose MS, Koshman ML, Spreng S, Sheldon R. The relationship between health-related quality of life and frequency of spells in patients with syncope. J Clin Epidemiol 2000;53:1209-16.
6. Kapoor WN. Syncope. N Engl J Med 2000;343:1856-62.
7. Li H, Weitzel M, Easley A, Barrington W, Windle J. Potential risk of vasovagal syncope for motor vehicle driving. Am J Cardiol 2000;85:184-6.
8. van Dijk JG. In a sweat over the riddle of reflex syncope. Clin Auton Res 2004;14: 212-3.
9. Drell D, Adamson A. Fast Forward to 2020: What to Expect in Molecular Medicine. http://www.ornl.gov/sci/techresources/Human-Genome/medicine/tnty. shtml (31 August 2008, date last accessed).
10. Collins FS, Green ED, Guttmacher AE, Guyer MS. A vision for the future of genomics research. Nature 2003;422:835-47.
11. Ganzeboom KS, Colman N, Reitsma JB, Shen WK, Wieling W. Prevalence and triggers of syncope in medical students. Am J Cardiol 2003;91:1006-8, A8.
12. Newman BH. Vasovagal reactions in high school students: findings relative to race, risk factor synergism, female sex, and non-high school participants. Transfusion 2002;42:1557-60.
13. Ioannidis JP, Boffetta P, Little J, O'Brian TR, Uitterlinden AG, Vineis P et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol 2008;37:120-32.
14. Talwar KK, Edvardsson N, Varnauskas E. Paroxysmal vagally mediated AV block with recurrent syncope. Clin Cardiol 1985;8:337-40.
15. Kleinknecht RA, Lenz J. Blood/injury fear, fainting and avoidance of medically-related situations: a family correspondence study. Behav Res Ther 1989;27:537-47.
16. Kleinknecht RA, Lenz J, Ford G, DeBerard S. Types and correlates of blood/ injury-related vasovagal syncope. Behav Res Ther 1990;28:289-95.
17. Camfield PR, Camfield CS. Syncope in childhood: a case control clinical study of the familial tendency to faint. Can J Neurol Sci 1990;17:306-8.
18. Cooper CJ, Ridker P, Shea J, Creager MA. Familial occurrence of neurocardiogenic syncope. N Engl J Med 1994;331:205.
19. Page AC, Martin NG. Testing a genetic structure of blood-injury-injection fears. Am J Med Genet 1998;81:377-84.
20. Mathias CJ, Deguchi K, Bleasdale-Barr K, Kimber JR. Frequency of family history in vasovagal syncope. Lancet 1998;352:33-4.
21. Mathias CJ, Deguchi K, Bleasdale-Barr K, Smith S. Familial vasovagal syncope and pseudosyncope: observations in a case with both natural and adopted siblings. Clin Auton Res 2000;10:43-5.
22. Mathias CJ, Deguchi K, Schatz I. Observations on recurrent syncope and presyncope in 641 patients. Lancet 2001;357:348-53.
23. Newton JL, Kenny R, Lawson J, Frearson R, Donaldson P. Prevalence of family history in vasovagal syncope and haemodynamic response to head up tilt in first degree relatives: preliminary data for the Newcastle cohort. Clin Auton Res 2003;13:22-6.
24. Newton JL, Kerr S, Pairman J, McLaren A, Norton M, Kenny RA et al. Familial neurocardiogenic (vasovagal) syncope. Am J Med Genet A 2005;133:176-9.
25. Newton JL, Donaldson P, Parry S, Kenny RA, Smith J, Gibson AM et al. Angiotensin converting enzyme insertion/deletion polymorphisms in vasovagal syncope. Europace 2005;7:396-9.
26. Marquez MF, Urias KI, Hermosillo AG, Jardon JL, Iturralde P, Colin L et al. Familial vasovagal syncope. Europace 2005;7:472-4.
27. Serletis A, Rose S, Sheldon AG, Sheldon RS. Vasovagal syncope in medical students and their first-degree relatives. Eur Heart J 2006;27:1965-70.
28. Lucas KE, Armenian HK, Petersen GM, Rowe PC. Familial aggregation of fainting in a case-control study of neurally mediated hypotension patients who present with unexplained chronic fatigue. Europace 2006;8:846-51.
29. O'Leary DD, Hughson RL, Shoemaker JK, Greaves DK, Watenpaugh DE, Macias BR et al. Heterogeneity of responses to orthostatic stress in homozygous twins. J Appl Physiol 2007;102:249-54.
30. Marquez MF, Hernandez-Pacheco G, Hermosillo AG, Gomez JR, Cardenas M, Vargas-Alarcon G. The Arg389Gly beta1-adrenergic receptor gene polymorphism and susceptibility to faint during head-up tilt test. Europace 2007;9:585-8.
31. Lelonek M, Pietrucha T, Stanczyk A, Goch JH. Vasovagal syncope patients and the C825T GNB3 polymorphism. Anadolu Kardiyol Derg 2007;7:206-8.
32. Carrega L, Saadjian AY, Mercier L, Zouher I, Berge-Lefranc JL, Gerolami V et al. Increased expression of adenosine A2A receptors in patients with spontaneous and head-up-tilt-induced syncope. Heart Rhythm 2007;4:870-6.
33. Thijs RD, Kruit MC, van Buchem MA, Ferrari MD, Launer LJ, van Dijk JG. Syncope in migraine: the population-based CAMERA study. Neurology 2006;66:1034-7.
34. Chen LY, Shen WK, Mahoney DW, Jacobsen SJ, Rodeheffer RJ. Prevalence of syncope in a population aged more than 45 years. Am J Med 2006;119:1088-7.
35. Ditto B, Adler PS, France C, France J. Family history of hypertension and vasovagal symptoms during blood donation. J Behav Med 1995;18:331-40.
36. Romme JJ, van Dijk N, Boer KR, Dekker LR, Stam J, Reitsma JB et al. Influence of age and gender on the occurrence and presentation of reflex syncope. Clin Auton Res 2008;18:127-33.
37. Toft E, Aaroe J, Jensen BT, Christiansen M, Fog L, Thomsen PEB et al. Long QT syndrome patients may faint due to neurocardiogenic syncope. Europace2003;5: 367-70.
38. Dietz NM, Rivera JM, Eggener SE, Fix RT, Warner DO, Joyner MJ. Nitric oxide contributes to the rise in forearm blood flow during mental stress in humans. J Physiol 1994;480:361-8.
39. el Bedawi KM, Wahbha MA, Hainsworth R. Cardiac pacing does not improve orthostatic tolerance in patients with vasovagal syncope. Clin Auton Res 1994;4: 233-7.
40. Kaufmann H, Hainsworth R. Why do we faint? Muscle Nerve 2001;24:981-3.
41. Vanderheyden M, Goethals M, Nellens P, Andries E, Brugada P. Different humoral responses during head-up tilt testing among patients with neurocardiogenic syncope. Am Heart J 1998;135:67-73.
42. Brewster L, van Dijk N, Mairuhu G, van Montfrans GA, Wieling W. Creatine kinase and the cumulative incidence of fainting in a random population sample. J Hypertens 2006;24:S304.
43. Jardine DL, Melton IC, Crozier IG, Bennett SI, Donald RA, Ikram H. Neurohor-monal response to head-up tilt and its role in vasovagal syncope. Am J Cardiol 1997;79:1302-6.
44. Douglas SA, Ohlstein EH. Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease. Trends Cardiovasc Med 2000;10:229-37.
45. Leiper J, Nandi M, Torondel B, Murray-Rust J, Malaki M, O'Hara B et al. Disruption of methylarginine metabolism impairs vascular homeostasis. Nat Med 2007;13: 198-203.
46. Karemaker JM, Wesseling KH. Variability in cardiovascular control: the baroreflex reconsidered. Cardiovasc Eng 2008;8:23-9.
47. Mehta AV, Chidambaram B, Garrett A. Familial symptomatic sinus bradycardia: autosomal dominant inheritance. Pediatr Cardiol 1995;16:231-4.
48. Cooke WH, Ludwig DA, Hogg PS, Eckberg DL, Convertino VA. Does the menstrual cycle influence the sensitivity of vagally mediated baroreflexes? Clin Sci (Lond) 2002;102:639-44.
49. Bosser G, Caillet G, Gauchard G, Marcon F, Perrin P. Relation between motion sickness susceptibility and vasovagal syncope susceptibility. Brain Res Bull 2006; 68:217-26.
50. Robertson D, Biaggioni I, Ertl AC, Robertson RM, Diedrich A, Blakely RD et al. Orthostatic intolerance: emerging genetic and environmental etiologies. J Gravit Physiol 1999;6:51-4.
51. Robertson D, Flattem N, Tellioglu T, Carson R, Garland E, Shannon JR et al. Familial orthostatic tachycardia due to norepinephrine transporter deficiency. Ann N Y Acad Sci 2001;940:527-43.
52. Garland EM, Black BK, Harris PA, Robertson D. Dopamine-beta-hydroxylase in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol 2007;293:H684-90.
53. Garland EM, Raj SR, Black BK, Harris PA, Robertson D. The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome. Neurology 2007;69: 790-8.
54. Vincent S, Robertson D. The broader view: catecholamine abnormalities. Clin Auton Res 2002;12:144-9.
55. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001;104:545-56.
56. Sprung J, Distel D, Grass J, Bloomfield EL, Lavery IC. Cardiovascular collapse during anesthesia in a patient with preoperatively discontinued chronic MAO inhibitor therapy. J Clin Anesth 1996;8:662-5.
57. Morris JA, Blount RL, Brown RT, Campbell RM. Association of parental psychological and behavioral factors and children's syncope. J Consult Clin Psychol 2001;69: 851-7.
58. Blount RL, Morris JA, Cheng PS, Campbell RM, Brown RT. Parent and child psychological factors in pediatric syncope and other somatic symptoms. J Consult Clin Psychol 2004;72:597-604.
59. Moss PD, McEvedy CP. An epidemic of overbreathing among schoolgirls. Br Med J 1966;2:1295-300.
60. Bouter LM, van Dongen MCJM, Zielhuis GA, Kiemeney LALM. Genetical epidemiology. In Bouter LM, Dongen MCJMv, Zielhuis GA (eds). Epidemiological Research: Set-up and Interpretation. Houten: Bohn Stafleu Van Loghum; 2005. p201-20.